Digital health in the management of allergic diseases

Digital health in the management of allergic diseases

Authors

  • Stefano Pattini Allergist-Clinical Immunologist, Pediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
  • Giuseppe Pingitore Pediatrician and Allergist, Rome
  • Fabio Cardinale Department of Pediatrics, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy
  • Amelia Licari Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy - Pediatric Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy
  • Michele Miraglia Del Giudice Department of woman, child and of general and specialized surgery, University of Campania ‘Luigi Vanvitelli’, Naples, Italy
  • Mauro Calvani UOC di Pediatria. Azienda ospedaliera S. Camillo Forlanini, Rome, Italy
  • Elena Chiappini Infectious Disease, Anna Meyer Children’s Hospital, Firenze, Italy
  • Claudio Cravidi Agenzia Tutela della Salute, ATS (National Healthcare System), Pavia, Italy
  • Gian Luigi Marseglia Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Pediatric Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy
  • Giampaolo Ricci Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy
  • Marzia Duse Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy
  • Salvatore Tripodi Allergology Service Policliclinico Casilino, Rome, Italy

Keywords:

telemedicine, apps, covid-19, immuno-allergic patients

Abstract

In recent years there has been an important implementation in the medical field of both Mobile Health, such as the use of mobile communication devices, and of other telemedicine tools in general, with the aim of supporting the supervision of diseases from the moment of the first diagnosis to the therapeutic follow-up. In fact, Digital Health can also have a very positive impact on the management of allergic patients, who are known to have the greatest need for regular monitoring, simplifying contact between doctor and patient, but there is still a need to improve implementation regulations, define certification programs and adequate reimbursement systems, as well as to guarantee a high level of attention to the protection of sensitive data. The hope is that one positive outcome of the Covid-19 pandemic will be an acceleration, by all stakeholders involved, of the process of the modernization of health care.

References

Matricardi PM, Dramburg S, Alvarez-Perea A et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy 2020;75:259-72.

Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19. J Allergy Clin Immunol Pract 2020;8:1489-91.

Brough HA, Kalayci O, Sediva A et al. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic. Pediatr Allergy Immunol 2020;31:442-48.

Shaker MS, Oppenheimer J, Grayson M et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract 2020;8:1477-88.

Hare N, Bansal P, Bajowala SS et al. Work group report: COVID-19: unmasking telemedicine. J Allergy Clin Immunol Pract 2020;8:2461–73.

Kaplan B. Revisiting health information technology ethical, legal, and social issues and evaluation: telehealth/telemedicine and covid-19. Int J Med Inform 2020;143:104239.

Omboni S. Telemedicine during the COVID-19 in Italy: a missed opportunity? Telemed J E Health 2020;26:973-75.

Nguyen M, Waller M, Pandya A et al. A review of patient and provider satisfaction with telemedicine. Curr Allergy Asthma Rep 2020;20:72.

Downloads

Published

29-11-2021

How to Cite

1.
Pattini S, Pingitore G, Cardinale F, Licari A, Miraglia Del Giudice M, Calvani M, et al. Digital health in the management of allergic diseases. Acta Biomed [Internet]. 2021 Nov. 29 [cited 2024 Jul. 17];92(S7):e2021529. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12405